Maze Therapeutics, Inc.
MAZE
$27.18
-$0.49-1.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.73M | -24.21M | -34.57M | -30.09M | -33.68M |
| Total Depreciation and Amortization | 391.00K | 444.00K | 499.00K | 571.00K | 649.00K |
| Total Amortization of Deferred Charges | 127.00K | 371.00K | -- | -- | -- |
| Total Other Non-Cash Items | 10.04M | 7.96M | 6.65M | 4.37M | 4.02M |
| Change in Net Operating Assets | 19.12M | -23.68M | -311.00K | 501.00K | -1.04M |
| Cash from Operations | -15.05M | -39.11M | -27.73M | -24.64M | -30.05M |
| Capital Expenditure | -107.00K | -93.00K | -34.00K | -68.00K | -393.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -128.40M | 6.37M | -103.35M | -66.82M | -- |
| Cash from Investing | -128.51M | 6.28M | -103.39M | -66.88M | -393.00K |
| Total Debt Issued | 0.00 | 39.40M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 148.35M | 4.08M | 3.59M | 143.76M | 3.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -917.00K | -1.12M | 0.00 | 0.00 | -2.45M |
| Cash from Financing | 147.44M | 42.36M | 3.59M | 143.76M | 612.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.88M | 9.52M | -127.53M | 52.23M | -29.83M |